SENNALAX-S- senna and docusate sodium tablet, film coated
Preferred Pharmaceuticals Inc.
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
----------
SennaLax-S Tablets
Uses
- •
- relieves occasional constipation (irregularity)
- •
- generally produces bowel movement in 6 to 12 hours
Do not use
- •
- laxative products for longer than 1 week unless told to do so by a doctor
- •
- if you are presently taking mineral oil, unless told to do so by a doctor
Ask a doctor before use if you have
- •
- stomach pain
- •
- nausea
- •
- vomiting
- •
- noticed a sudden change in bowel habits that lasts over 2 weeks
Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These could be signs of a serious condition.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Directions
- •
- take preferably at bedtime or as directed by a doctor
|
age |
starting dose |
maximum dosage |
|
adults & children 12 years and over |
2 tablets once a day |
4 tablets twice a day |
|
children 6 to under 12 years |
1 tablet once a day |
2 tablets twice a day |
|
children 2 to under 6 years |
1/2 tablet once a day |
1 tablet twice a day |
|
children under 2 years |
ask a doctor |
ask a doctor |
Other information
- •
- each tablet contains: calcium 30 mg, sodium 3 mg VERY LOW SODIUM
- •
- do not use if imprinted safety seal under cap is missing or damaged.
- •
- store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F).
- •
- keep tightly closed.
You may report serious side effects to: 130 Vintage Drive, Huntsville, AL 35811.
Inactive ingredients
colloidal silicon dioxide, D&C yellow No. 10, dicalcium phosphate, ethanol, FD&C yellow No. 6, hypromellose, magnesium stearate, microcrystalline cellulose, mineral oil, polyethylene glycol, pregelatinized starch, silicon dioxide, sodium benzoate, stearic acid, talc, titanium dioxide.
| SENNALAX-S
senna and docusate sodium tablet, film coated |
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
| Labeler - Preferred Pharmaceuticals Inc. (791119022) |
| Registrant - Preferred Pharmaceuticals Inc. (791119022) |
| Establishment | |||
| Name | Address | ID/FEI | Business Operations |
|---|---|---|---|
| Preferred Pharmaceuticals Inc. | 791119022 | REPACK(68788-0848) | |